miR-155 promotes FLT3-ITD–induced myeloproliferative disease through inhibition of the interferon response

Por Wallace, Jared A., Kagele, Dominique A., Eiring, Anna M., Kim, Carissa N., Hu, Ruozhen, Runtsch, Marah C., Alexander, Margaret, Huffaker, Thomas B., Lee, Soh-Hyun, Patel, Ami B., Mosbruger, Timothy L., Voth, Warren P., Rao, Dinesh S., Miles, Rodney R., Round, June L., Deininger, Michael W., O’Connell, Ryan M.
Publicado no Blood (2017)